HCPCS J Codes – Drugs Administered Other Than Oral Method

• J0013 – Esketamine, nasal spray, 1 mg
• J0014 – Cocaine hydrochloride nasal solution (goprelto), 1 mg
• J0120 – Injection, tetracycline, up to 250 mg
• J0121 – Injection, omadacycline, 1 mg
• J0122 – Injection, eravacycline, 1 mg
• J0129 – Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
• J0130 – Injection abciximab, 10 mg
• J0131 – Injection, acetaminophen, not otherwise specified,10 mg
• J0132 – Injection, acetylcysteine, 100 mg
• J0133 – Injection, acyclovir, 5 mg
• J0134 – Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg
• J0136 – Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg
• J0137 – Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg
• J0138 – Injection, acetaminophen 10 mg and ibuprofen 3 mg
• J0139 – Injection, adalimumab, 1 mg
• J0153 – Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)
• J0162 – Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mg
• J0163 – Injection, epinephrine in sodium chloride (endo), 0.1 mg
• J0164 – Injection, epinephrine in sodium chloride (baxter), 0.1 mg
• J0165 – Injection, epinephrine, not otherwise specified, 0.1 mg
• J0166 – Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg
• J0167 – Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg
• J0168 – Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mg
• J0169 – Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, 0.1 mg
• J0174 – Lecanemab-irmb, for intravenous injection, 1 mg
• J0175 – Injection, donanemab-azbt, 2 mg
• J0177 – Injection, aflibercept hd, 1 mg
• J0178 – Injection, aflibercept, 1 mg
• J0179 – Injection, brolucizumab-dbll, 1 mg
• J0180 – Injection, agalsidase beta, 1 mg
• J0184 – Injection, amisulpride, 1 mg
• J0185 – Injection, aprepitant, 1 mg
• J0202 – Injection, alemtuzumab, 1 mg
• J0206 – Injection, allopurinol sodium, 1 mg
• J0207 – Injection, amifostine, 500 mg
• J0208 – Injection, sodium thiosulfate (pedmark), 100 mg
• J0209 – Injection, sodium thiosulfate (hope), 100 mg
• J0210 – Injection, methyldopate hcl, up to 250 mg
• J0211 – Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)
• J0216 – Injection, alfentanil hydrochloride, 500 micrograms
• J0217 – Injection, velmanase alfa-tycv, 1 mg
• J0218 – Injection, olipudase alfa-rpcp, 1 mg
• J0219 – Injection, avalglucosidase alfa-ngpt, 4 mg
• J0220 – Injection, alglucosidase alfa, 10 mg, not otherwise specified
• J0221 – Injection, alglucosidase alfa, (lumizyme), 10 mg
• J0222 – Injection, patisiran, 0.1 mg
• J0223 – Injection, givosiran, 0.5 mg
• J0224 – Injection, lumasiran, 0.5 mg
• J0225 – Injection, vutrisiran, 1 mg
• J0248 – Injection, remdesivir, 1 mg
• J0256 – Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg
• J0257 – Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg
• J0270 – Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
• J0275 – Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
• J0278 – Injection, amikacin sulfate, 100 mg
• J0280 – Injection, aminophyllin, up to 250 mg
• J0281 – Injection, aminocaproic acid, 1 gram
• J0282 – Injection, amiodarone hydrochloride, 30 mg
• J0283 – Injection, amiodarone hydrochloride (nexterone), 30 mg
• J0285 – Injection, amphotericin b, 50 mg
• J0287 – Injection, amphotericin b lipid complex, 10 mg
• J0289 – Injection, amphotericin b liposome, 10 mg
• J0290 – Injection, ampicillin sodium, 500 mg
• J0291 – Injection, plazomicin, 5 mg
• J0295 – Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm
• J0300 – Injection, amobarbital, up to 125 mg
• J0330 – Injection, succinylcholine chloride, up to 20 mg
• J0348 – Injection, anidulafungin, 1 mg
• J0349 – Injection, rezafungin, 1 mg
• J0360 – Injection, hydralazine hcl, up to 20 mg
• J0364 – Injection, apomorphine hydrochloride, 1 mg
• J0390 – Injection, chloroquine hydrochloride, up to 250 mg
• J0391 – Injection, artesunate, 1 mg
• J0400 – Injection, aripiprazole, intramuscular, 0.25 mg
• J0401 – Injection, aripiprazole (abilify maintena), 1 mg
• J0402 – Injection, aripiprazole (abilify asimtufii), 1 mg
• J0456 – Injection, azithromycin, 500 mg
• J0457 – Injection, aztreonam, 100 mg
• J0458 – Injection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg)
• J0461 – Injection, atropine sulfate, 0.01 mg
• J0462 – Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mg
• J0463 – Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg
• J0470 – Injection, dimercaprol, per 100 mg
• J0475 – Injection, baclofen, 10 mg
• J0476 – Injection, baclofen, 50 mcg for intrathecal trial
• J0480 – Injection, basiliximab, 20 mg
• J0485 – Injection, belatacept, 1 mg
• J0490 – Injection, belimumab, 10 mg
• J0491 – Injection, anifrolumab-fnia, 1 mg
• J0500 – Injection, dicyclomine hcl, up to 20 mg
• J0515 – Injection, benztropine mesylate, per 1 mg
• J0517 – Injection, benralizumab, 1 mg
• J0520 – Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg
• J0525 – Injection, cefotetan disodium, 10 mg
• J0528 – Injection, fosfomycin disodium, 20 mg
• J0558 – Injection, penicillin g benzathine and penicillin g procaine, 100,000 units
• J0561 – Injection, penicillin g benzathine, 100,000 units
• J0565 – Injection, bezlotoxumab, 10 mg
• J0567 – Injection, cerliponase alfa, 1 mg
• J0570 – Buprenorphine implant, 74.2 mg
• J0571 – Buprenorphine, oral, 1 mg
• J0572 – Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine
• J0573 – Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine
• J0574 – Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine
• J0575 – Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine
• J0577 – Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
• J0578 – Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy
• J0582 – Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg
• J0583 – Injection, bivalirudin, 1 mg
• J0584 – Injection, burosumab-twza 1 mg
• J0585 – Injection, onabotulinumtoxina, 1 unit
• J0586 – Injection, abobotulinumtoxina, 5 units
• J0587 – Injection, rimabotulinumtoxinb, 100 units
• J0588 – Injection, incobotulinumtoxin a, 1 unit
• J0589 – Injection, daxibotulinumtoxina-lanm, 1 unit
• J0591 – Injection, deoxycholic acid, 1 mg
• J0592 – Injection, buprenorphine hydrochloride, 0.1 mg
• J0593 – Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)
• J0594 – Injection, busulfan, 1 mg
• J0595 – Injection, butorphanol tartrate, 1 mg
• J0596 – Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units
• J0597 – Injection, c-1 esterase inhibitor (human), berinert, 10 units
• J0598 – Injection, c-1 esterase inhibitor (human), cinryze, 10 units
• J0599 – Injection, c-1 esterase inhibitor (human), (haegarda), 10 units
• J0600 – Injection, edetate calcium disodium, up to 1000 mg
• J0601 – Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)
• J0602 – Sevelamer carbonate (renvela or therapeutically equivalent), oral, powder, 20 mg (for esrd on dialysis)
• J0603 – Sevelamer hydrochloride (renagel or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)
• J0604 – Cinacalcet, oral, 1 mg, (for esrd on dialysis)
• J0605 – Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)
• J0606 – Injection, etelcalcetide, 0.1 mg
• J0607 – Lanthanum carbonate, oral, 5 mg (for esrd on dialysis)
• J0608 – Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)
• J0609 – Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)
• J0612 – Injection, calcium gluconate, not otherwise specified, 10 mg
• J0613 – Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg
• J0614 – Injection, treosulfan, 50 mg
• J0615 – Calcium acetate, oral, 23 mg (for esrd on dialysis)
• J0616 – Injection, metoprolol tartrate, 1 mg
• J0618 – Injection, calcium chloride, 2 mg
• J0620 – Injection, calcium glycerophosphate and calcium lactate, per 10 ml
• J0630 – Injection, calcitonin salmon, up to 400 units
• J0636 – Injection, calcitriol, 0.1 mcg
• J0637 – Injection, caspofungin acetate, 5 mg
• J0638 – Injection, canakinumab, 1 mg
• J0641 – Injection, levoleucovorin, not otherwise specified, 0.5 mg
• J0642 – Injection, levoleucovorin (khapzory), 0.5 mg
• J0643 – Injection, leucovorin calcium, not otherwise specified, 1 mg
• J0644 – Injection, leucovorin calcium (avyxa), 1 mg
• J0650 – Injection, levothyroxine sodium, not otherwise specified, 10 mcg
• J0651 – Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg
• J0652 – Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg
• J0654 – Injection, liothyronine, 1 mcg
• J0665 – Injection, bupivicaine, not otherwise specified, 0.5 mg
• J0666 – Injection, bupivacaine liposome, 1 mg
• J0668 – Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg
• J0670 – Injection, mepivacaine hydrochloride, per 10 ml
• J0675 – Injection, carboprost tromethamine, 0.1 mg
• J0681 – Injection, ceftobiprole medocaril sodium, 3 mg
• J0687 – Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg
• J0688 – Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg
• J0689 – Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg
• J0690 – Injection, cefazolin sodium, 500 mg
• J0691 – Injection, lefamulin, 1 mg
• J0692 – Injection, cefepime hydrochloride, 500 mg
• J0694 – Injection, cefoxitin sodium, 1 gm
• J0695 – Injection, ceftolozane 50 mg and tazobactam 25 mg
• J0696 – Injection, ceftriaxone sodium, per 250 mg
• J0697 – Injection, sterile cefuroxime sodium, per 750 mg
• J0698 – Injection, cefotaxime sodium, per gm
• J0699 – Injection, cefiderocol, 10 mg
• J0701 – Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
• J0702 – Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
• J0703 – Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg
• J0706 – Injection, caffeine citrate, 5 mg
• J0712 – Injection, ceftaroline fosamil, 10 mg
• J0713 – Injection, ceftazidime, per 500 mg
• J0714 – Injection, ceftazidime and avibactam, 0.5 g/0.125 g
• J0716 – Injection, centruroides immune f(ab)2, up to 120 milligrams
• J0717 – Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
• J0720 – Injection, chloramphenicol sodium succinate, up to 1 gm
• J0725 – Injection, chorionic gonadotropin, per 1,000 usp units
• J0735 – Injection, clonidine hydrochloride, 1 mg
• J0736 – Injection, clindamycin phosphate, 300 mg
• J0737 – Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg
• J0738 – Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
• J0739 – Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
• J0740 – Injection, cidofovir, 375 mg
• J0741 – Injection, cabotegravir and rilpivirine, 2mg/3mg
• J0742 – Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg
• J0743 – Injection, cilastatin sodium; imipenem, per 250 mg
• J0744 – Injection, ciprofloxacin for intravenous infusion, 200 mg
• J0745 – Injection, codeine phosphate, per 30 mg
• J0750 – Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
• J0751 – Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
• J0752 – Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
• J0759 – Injection, clevidipine butyrate, 1 mg
• J0770 – Injection, colistimethate sodium, up to 150 mg
• J0775 – Injection, collagenase, clostridium histolyticum, 0.01 mg
• J0780 – Injection, prochlorperazine, up to 10 mg
• J0791 – Injection, crizanlizumab-tmca, 5 mg
• J0799 – Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified
• J0801 – Injection, corticotropin (acthar gel), up to 40 units
• J0802 – Injection, corticotropin (ani), up to 40 units
• J0834 – Injection, cosyntropin, 0.25 mg
• J0840 – Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram
• J0841 – Injection, crotalidae immune f(ab')2 (equine), 120 mg
• J0850 – Injection, cytomegalovirus immune globulin intravenous (human), per vial
• J0870 – Injection, imetelstat, 1 mg
• J0871 – Injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mg
• J0872 – Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
• J0873 – Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg
• J0874 – Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg
• J0875 – Injection, dalbavancin, 5 mg
• J0877 – Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg
• J0878 – Injection, daptomycin, 1 mg
• J0879 – Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)
• J0881 – Injection, darbepoetin alfa, 1 microgram (non-esrd use)
• J0882 – Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)
• J0883 – Injection, argatroban, 1 mg (for non-esrd use)
• J0884 – Injection, argatroban, 1 mg (for esrd on dialysis)
• J0885 – Injection, epoetin alfa, (for non-esrd use), 1000 units
• J0887 – Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
• J0888 – Injection, epoetin beta, 1 microgram, (for non esrd use)
• J0890 – Injection, peginesatide, 0.1 mg (for esrd on dialysis)
• J0891 – Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
• J0892 – Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
• J0893 – Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
• J0894 – Injection, decitabine, 1 mg
• J0895 – Injection, deferoxamine mesylate, 500 mg
• J0896 – Injection, luspatercept-aamt, 0.25 mg
• J0897 – Injection, denosumab, 1 mg
• J0898 – Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
• J0899 – Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
• J0901 – Vadadustat, oral, 1 mg (for esrd on dialysis)
• J0911 – Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous catheter lock for adult patients receiving chronic hemodialysis)
• J0945 – Injection, brompheniramine maleate, per 10 mg
• J1000 – Injection, depo-estradiol cypionate, up to 5 mg
• J1010 – Injection, methylprednisolone acetate, 1 mg
• J1050 – Injection, medroxyprogesterone acetate, 1 mg
• J1071 – Injection, testosterone cypionate, 1 mg
• J1072 – Injection, testosterone cypionate (azmiro), 1 mg
• J1073 – Testosterone pellet, implant, 75 mg
• J1095 – Injection, dexamethasone 9 percent, intraocular, 1 microgram
• J1096 – Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
• J1097 – Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml
• J1098 – Articaine ophthalmic, 8% solution, 0.4 ml
• J1100 – Injection, dexamethasone sodium phosphate, 1 mg
• J1105 – Dexmedetomidine, oral, 1 mcg
• J1110 – Injection, dihydroergotamine mesylate, per 1 mg
• J1120 – Injection, acetazolamide sodium, up to 500 mg
• J1130 – Injection, diclofenac sodium, 0.5 mg
• J1160 – Injection, digoxin, up to 0.5 mg
• J1162 – Injection, digoxin immune fab (ovine), per vial
• J1163 – Injection, diltiazem hydrochloride, 0.5 mg
• J1164 – Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg
• J1165 – Injection, phenytoin sodium, per 50 mg
• J1171 – Injection, hydromorphone, 0.1 mg
• J1180 – Injection, dyphylline, up to 500 mg
• J1190 – Injection, dexrazoxane hydrochloride, per 250 mg
• J1200 – Injection, diphenhydramine hcl, up to 50 mg
• J1201 – Injection, cetirizine hydrochloride, 0.5 mg
• J1202 – Miglustat, oral, 65 mg
• J1203 – Injection, cipaglucosidase alfa-atga, 5 mg
• J1205 – Injection, chlorothiazide sodium, per 500 mg
• J1212 – Injection, dmso, dimethyl sulfoxide, 50%, 50 ml
• J1230 – Injection, methadone hcl, up to 10 mg
• J1240 – Injection, dimenhydrinate, up to 50 mg
• J1245 – Injection, dipyridamole, per 10 mg
• J1250 – Injection, dobutamine hydrochloride, per 250 mg
• J1260 – Injection, dolasetron mesylate, 10 mg
• J1265 – Injection, dopamine hcl, 40 mg
• J1270 – Injection, doxercalciferol, 1 mcg
• J1271 – Injection, doxycycline hyclate, 1 mg
• J1289 – Injection, narsoplimab-wuug, 1 mg
• J1290 – Injection, ecallantide, 1 mg
• J1299 – Injection, eculizumab, 2 mg
• J1301 – Injection, edaravone, 1 mg
• J1302 – Injection, sutimlimab-jome, 10 mg
• J1303 – Injection, ravulizumab-cwvz, 10 mg
• J1304 – Injection, tofersen, 1 mg
• J1305 – Injection, evinacumab-dgnb, 5mg
• J1306 – Injection, inclisiran, 1 mg
• J1307 – Injection, crovalimab-akkz, 10 mg
• J1308 – Injection, famotidine, 0.25 mg
• J1320 – Injection, amitriptyline hcl, up to 20 mg
• J1322 – Injection, elosulfase alfa, 1 mg
• J1323 – Injection, elranatamab-bcmm, 1 mg
• J1324 – Injection, enfuvirtide, 1 mg
• J1325 – Injection, epoprostenol, 0.5 mg
• J1326 – Injection, zolbetuximab-clzb, 2 mg
• J1327 – Injection, eptifibatide, 5 mg
• J1335 – Injection, ertapenem sodium, 500 mg
• J1364 – Injection, erythromycin lactobionate, per 500 mg
• J1370 – Injection, esomeprazole sodium, 1 mg
• J1380 – Injection, estradiol valerate, up to 10 mg
• J1410 – Injection, estrogen conjugated, per 25 mg
• J1411 – Injection, etranacogene dezaparvovec-drlb, per therapeutic dose
• J1412 – Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes
• J1413 – Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose
• J1414 – Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose
• J1426 – Injection, casimersen, 10 mg
• J1427 – Injection, viltolarsen, 10 mg
• J1428 – Injection, eteplirsen, 10 mg
• J1429 – Injection, golodirsen, 10 mg
• J1430 – Injection, ethanolamine oleate, 100 mg
• J1434 – Injection, fosaprepitant (focinvez), 1 mg
• J1435 – Injection, estrone, per 1 mg
• J1436 – Injection, etidronate disodium, per 300 mg
• J1437 – Injection, ferric derisomaltose, 10 mg
• J1438 – Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
• J1439 – Injection, ferric carboxymaltose, 1 mg
• J1440 – Fecal microbiota, live - jslm, 1 ml
• J1442 – Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram
• J1447 – Injection, tbo-filgrastim, 1 microgram
• J1448 – Injection, trilaciclib, 1mg
• J1449 – Injection, eflapegrastim-xnst, 0.1 mg
• J1450 – Injection fluconazole, 200 mg
• J1451 – Injection, fomepizole, 15 mg
• J1453 – Injection, fosaprepitant, 1 mg
• J1454 – Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
• J1455 – Injection, foscarnet sodium, per 1000 mg
• J1456 – Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg
• J1458 – Injection, galsulfase, 1 mg
• J1459 – Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg
• J1460 – Injection, gamma globulin, intramuscular, 1 cc
• J1551 – Injection, immune globulin (cutaquig), 100 mg
• J1552 – Injection, immune globulin (alyglo), 500 mg
• J1553 – Injection, immune globulin (yimmugo), 100 mg
• J1554 – Injection, immune globulin (asceniv), 500 mg
• J1555 – Injection, immune globulin (cuvitru), 100 mg
• J1556 – Injection, immune globulin (bivigam), 500 mg
• J1557 – Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg
• J1558 – Injection, immune globulin (xembify), 100 mg
• J1559 – Injection, immune globulin (hizentra), 100 mg
• J1560 – Injection, gamma globulin, intramuscular, over 10 cc
• J1561 – Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
• J1566 – Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
• J1568 – Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
• J1569 – Injection, immune globulin, (gammagard liquid/gammagard liquid erc), 500 mg
• J1570 – Injection, ganciclovir sodium, 500 mg
• J1571 – Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml
• J1572 – Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg
• J1573 – Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml
• J1574 – Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg
• J1575 – Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin
• J1576 – Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg
• J1577 – Injection, immune globulin (qivigy), 100 mg
• J1580 – Injection, garamycin, gentamicin, up to 80 mg
• J1595 – Injection, glatiramer acetate, 20 mg
• J1596 – Injection, glycopyrrolate, 0.1 mg
• J1597 – Injection, glycopyrrolate (glyrx-pf), 0.1 mg
• J1598 – Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg
• J1599 – Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg
• J1600 – Injection, gold sodium thiomalate, up to 50 mg
• J1602 – Injection, golimumab, 1 mg, for intravenous use
• J1610 – Injection, glucagon hydrochloride, per 1 mg
• J1611 – Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg
• J1612 – Injection, glucagon (gvoke), 0.01 mg
• J1626 – Injection, granisetron hydrochloride, 100 mcg
• J1627 – Injection, granisetron, extended-release, 0.1 mg
• J1628 – Injection, guselkumab, 1 mg
• J1630 – Injection, haloperidol, up to 5 mg
• J1631 – Injection, haloperidol decanoate, per 50 mg
• J1632 – Injection, brexanolone, 1 mg
• J1640 – Injection, hemin, 1 mg
• J1642 – Injection, heparin sodium, (heparin lock flush), per 10 units
• J1643 – Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units
• J1644 – Injection, heparin sodium, per 1000 units
• J1645 – Injection, dalteparin sodium, per 2500 iu
• J1650 – Injection, enoxaparin sodium, 10 mg
• J1652 – Injection, fondaparinux sodium, 0.5 mg
• J1670 – Injection, tetanus immune globulin, human, up to 250 units
• J1675 – Injection, histrelin acetate, 10 micrograms
• J1700 – Injection, hydrocortisone acetate, up to 25 mg
• J1720 – Injection, hydrocortisone sodium succinate, up to 100 mg
• J1726 – Injection, hydroxyprogesterone caproate, (makena), 10 mg
• J1729 – Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
• J1730 – Injection, diazoxide, up to 300 mg
• J1736 – Injection, meloxicam (delova), 1 mg
• J1737 – Injection, meloxicam (azurity), 1 mg
• J1738 – Injection, meloxicam, 1 mg
• J1740 – Injection, ibandronate sodium, 1 mg
• J1741 – Injection, ibuprofen, 100 mg
• J1742 – Injection, ibutilide fumarate, 1 mg
• J1743 – Injection, idursulfase, 1 mg
• J1744 – Injection, icatibant, 1 mg
• J1745 – Injection, infliximab, excludes biosimilar, 10 mg
• J1746 – Injection, ibalizumab-uiyk, 10 mg
• J1747 – Injection, spesolimab-sbzo, 1 mg
• J1748 – Injection, infliximab-dyyb (zymfentra), 10 mg
• J1749 – Injection, iloprost, 0.1 mcg
• J1750 – Injection, iron dextran, 50 mg
• J1756 – Injection, iron sucrose, 1 mg
• J1757 – Injection, tividenofusp alfa-eknm, 1 mg
• J1786 – Injection, imiglucerase, 10 units
• J1790 – Injection, droperidol, up to 5 mg
• J1800 – Injection, propranolol hcl, up to 1 mg
• J1805 – Injection, esmolol hydrochloride, 10 mg
• J1806 – Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg
• J1807 – Injection, ethacrynate sodium, 1 mg
• J1808 – Injection, folic acid, 0.1 mg
• J1809 – Injection, fosdenopterin, 0.1 mg
• J1811 – Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units
• J1812 – Insulin (fiasp), per 5 units
• J1813 – Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units
• J1814 – Insulin (lyumjev), per 5 units
• J1815 – Injection, insulin, per 5 units
• J1817 – Insulin for administration through dme (i.e., insulin pump) per 50 units
• J1818 – Injection, pegzilarginase-nbln, 0.05 mg
• J1823 – Injection, inebilizumab-cdon, 1 mg
• J1826 – Injection, interferon beta-1a, 30 mcg
• J1830 – Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
• J1833 – Injection, isavuconazonium, 1 mg
• J1834 – Injection, isoniazid, 1 mg
• J1835 – Injection, itraconazole, 50 mg
• J1836 – Injection, metronidazole, 10 mg
• J1837 – Injection, posaconazole, 1 mg
• J1885 – Injection, ketorolac tromethamine, per 15 mg
• J1920 – Injection, labetalol hydrochloride, 5 mg
• J1921 – Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg
• J1930 – Injection, lanreotide, 1 mg
• J1931 – Injection, laronidase, 0.1 mg
• J1932 – Injection, lanreotide, (cipla), 1 mg
• J1938 – Injection, furosemide, 1 mg
• J1939 – Injection, bumetanide, 0.5 mg
• J1943 – Injection, aripiprazole lauroxil, (aristada initio), 1 mg
• J1944 – Injection, aripiprazole lauroxil, (aristada), 1 mg
• J1946 – Injection, furosemide (lasix onyu), 1 mg
• J1947 – Injection, furosemide (furoscix), 1 mg
• J1950 – Injection, leuprolide acetate (for depot suspension), per 3.75 mg
• J1951 – Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg
• J1952 – Leuprolide injectable, camcevi, 1 mg
• J1954 – Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg
• J1955 – Injection, levocarnitine, per 1 gm
• J1956 – Injection, levofloxacin, 250 mg
• J1957 – Injection, levetiracetam, 5 mg
• J1958 – Injection, levetiracetam in sodium chloride, 5 mg
• J1960 – Injection, levorphanol tartrate, up to 2 mg
• J1961 – Injection, lenacapavir (only for use as hiv treatment), 1 mg
• J1980 – Injection, hyoscyamine sulfate, up to 0.25 mg
• J1990 – Injection, chlordiazepoxide hcl, up to 100 mg
• J2002 – Injection, lidocaine hcl in 5% dextrose, 1 mg
• J2003 – Injection, lidocaine hydrochloride, 1 mg
• J2004 – Injection, lidocaine hcl with epinephrine, 1 mg
• J2010 – Injection, lincomycin hcl, up to 300 mg
• J2020 – Injection, linezolid, 200 mg
• J2021 – Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg
• J2060 – Injection, lorazepam, 2 mg
• J2062 – Loxapine for inhalation, 1 mg
• J2151 – Injection, mannitol, 250 mg
• J2170 – Injection, mecasermin, 1 mg
• J2175 – Injection, meperidine hydrochloride, per 100 mg
• J2180 – Injection, meperidine and promethazine hcl, up to 50 mg
• J2182 – Injection, mepolizumab, 1 mg
• J2183 – Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg
• J2184 – Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg
• J2185 – Injection, meropenem, 100 mg
• J2186 – Injection, meropenem and vaborbactam, 10mg/10mg (20mg)
• J2210 – Injection, methylergonovine maleate, up to 0.2 mg
• J2212 – Injection, methylnaltrexone, 0.1 mg
• J2246 – Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg
• J2247 – Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg
• J2248 – Injection, micafungin sodium, 1 mg
• J2249 – Injection, remimazolam, 1 mg
• J2250 – Injection, midazolam hydrochloride, per 1 mg
• J2251 – Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
• J2252 – Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
• J2253 – Injection, midazolam (seizalam), 1 mg
• J2260 – Injection, milrinone lactate, 5 mg
• J2265 – Injection, minocycline hydrochloride, 1 mg
• J2267 – Injection, mirikizumab-mrkz, 1 mg
• J2270 – Injection, morphine sulfate, up to 10 mg
• J2272 – Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg
• J2274 – Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
• J2277 – Injection, motixafortide, 0.25 mg
• J2278 – Injection, ziconotide, 1 microgram
• J2280 – Injection, moxifloxacin, 100 mg
• J2281 – Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg
• J2290 – Injection, nafcillin sodium, 20 mg
• J2291 – Injection, nafcillin sodium (baxter), 20 mg
• J2300 – Injection, nalbuphine hydrochloride, per 10 mg
• J2305 – Injection, nitroglycerin, 5 mg
• J2312 – Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg
• J2313 – Injection, naloxone hydrochloride (zimhi), 0.01 mg
• J2315 – Injection, naltrexone, depot form, 1 mg
• J2320 – Injection, nandrolone decanoate, up to 50 mg
• J2323 – Injection, natalizumab, 1 mg
• J2325 – Injection, nesiritide, 0.1 mg
• J2326 – Injection, nusinersen, 0.1 mg
• J2327 – Injection, risankizumab-rzaa, intravenous, 1 mg
• J2329 – Injection, ublituximab-xiiy, 1mg
• J2350 – Injection, ocrelizumab, 1 mg
• J2351 – Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq
• J2353 – Injection, octreotide, depot form for intramuscular injection, 1 mg
• J2354 – Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg
• J2355 – Injection, oprelvekin, 5 mg
• J2356 – Injection, tezepelumab-ekko, 1 mg
• J2357 – Injection, omalizumab, 5 mg
• J2358 – Injection, olanzapine, long-acting, 1 mg
• J2359 – Injection, olanzapine, 0.5 mg
• J2360 – Injection, orphenadrine citrate, up to 60 mg
• J2361 – Injection, depemokimab-ulaa, 1 mg
• J2371 – Injection, phenylephrine hydrochloride, 20 micrograms
• J2372 – Injection, phenylephrine hydrochloride (biorphen), 20 micrograms
• J2373 – Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms
• J2374 – Apraclonidine hydrochloride ophthalmic, 1% solution, 0.1 ml
• J2401 – Injection, chloroprocaine hydrochloride, per 1 mg
• J2402 – Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg
• J2403 – Chloroprocaine hcl ophthalmic, 3% gel, 1 mg
• J2404 – Injection, nicardipine, 0.1 mg
• J2405 – Injection, ondansetron hydrochloride, per 1 mg
• J2406 – Injection, oritavancin (kimyrsa), 10 mg
• J2407 – Injection, oritavancin (orbactiv), 10 mg
• J2410 – Injection, oxymorphone hcl, up to 1 mg
• J2425 – Injection, palifermin, 50 micrograms
• J2426 – Injection, paliperidone palmitate extended release (invega sustenna), 1 mg
• J2427 – Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
• J2428 – Injection, paliperidone palmitate extended release (erzofri), 1 mg
• J2430 – Injection, pamidronate disodium, per 30 mg
• J2440 – Injection, papaverine hcl, up to 60 mg
• J2460 – Injection, oxytetracycline hcl, up to 50 mg
• J2468 – Injection, palonosetron hydrochloride (posfrea), 25 micrograms
• J2469 – Injection, palonosetron hcl, 25 mcg
• J2470 – Injection, pantoprazole sodium, 40 mg
• J2471 – Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg
• J2472 – Injection, pantoprazole sodium in sodium chloride (baxter), 40 mg
• J2501 – Injection, paricalcitol, 1 mcg
• J2502 – Injection, pasireotide long acting, 1 mg
• J2506 – Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
• J2507 – Injection, pegloticase, 1 mg
• J2508 – Injection, pegunigalsidase alfa-iwxj, 1 mg
• J2510 – Injection, penicillin g procaine, aqueous, up to 600,000 units
• J2515 – Injection, pentobarbital sodium, per 50 mg
• J2516 – Injection, pentamidine isethionate, 1 mg
• J2540 – Injection, penicillin g potassium, up to 600,000 units
• J2543 – Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)
• J2545 – Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg
• J2547 – Injection, peramivir, 1 mg
• J2550 – Injection, promethazine hcl, up to 50 mg
• J2560 – Injection, phenobarbital sodium, up to 120 mg
• J2561 – Injection, phenobarbital sodium (sezaby), 1 mg
• J2562 – Injection, plerixafor, 1 mg
• J2590 – Injection, oxytocin, up to 10 units
• J2596 – Injection, vasopressin (long grove), not therapeutically equivalent to j2598, 1 unit
• J2597 – Injection, desmopressin acetate, per 1 mcg
• J2598 – Injection, vasopressin, 1 unit
• J2599 – Injection, vasopressin (american regent), not therapeutically equivalent to j2598, 1 unit
• J2601 – Injection, vasopressin (baxter), 1 unit
• J2650 – Injection, prednisolone acetate, up to 1 ml
• J2670 – Injection, tolazoline hcl, up to 25 mg
• J2675 – Injection, progesterone, per 50 mg
• J2679 – Injection, fluphenazine hcl, 1.25 mg
• J2680 – Injection, fluphenazine decanoate, up to 25 mg
• J2690 – Injection, procainamide hcl, up to 1 gm
• J2700 – Injection, oxacillin sodium, up to 250 mg
• J2704 – Injection, propofol, 10 mg
• J2710 – Injection, neostigmine methylsulfate, up to 0.5 mg
• J2711 – Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg
• J2720 – Injection, protamine sulfate, per 10 mg
• J2724 – Injection, protein c concentrate, intravenous, human, 10 iu
• J2725 – Injection, protirelin, per 250 mcg
• J2730 – Injection, pralidoxime chloride, up to 1 gm
• J2760 – Injection, phentolamine mesylate, up to 5 mg
• J2765 – Injection, metoclopramide hcl, up to 10 mg
• J2770 – Injection, quinupristin/dalfopristin, 500 mg (150/350)
• J2777 – Injection, faricimab-svoa, 0.1 mg
• J2778 – Injection, ranibizumab, 0.1 mg
• J2779 – Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg
• J2781 – Injection, pegcetacoplan, intravitreal, 1 mg
• J2782 – Injection, avacincaptad pegol, 0.1 mg
• J2783 – Injection, rasburicase, 0.5 mg
• J2785 – Injection, regadenoson, 0.1 mg
• J2786 – Injection, reslizumab, 1 mg
• J2787 – Riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 ml
• J2788 – Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)
• J2789 – Riboflavin 5'-phosphate, ophthalmic solution (epioxahd/epioxa), up to 2 ml
• J2790 – Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)
• J2791 – Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu
• J2792 – Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu
• J2793 – Injection, rilonacept, 1 mg
• J2794 – Injection, risperidone (risperdal consta), 0.5 mg
• J2795 – Injection, ropivacaine hydrochloride, 1 mg
• J2797 – Injection, rolapitant, 0.5 mg
• J2798 – Injection, risperidone, (perseris), 0.5 mg
• J2799 – Injection, risperidone (uzedy), 1 mg
• J2800 – Injection, methocarbamol, up to 10 ml
• J2801 – Injection, risperidone (rykindo), 0.5 mg
• J2802 – Injection, romiplostim, 1 microgram
• J2804 – Injection, rifampin, 1 mg
• J2805 – Injection, sincalide, 5 micrograms
• J2810 – Injection, theophylline, per 40 mg
• J2820 – Injection, sargramostim (gm-csf), 50 mcg
• J2840 – Injection, sebelipase alfa, 1 mg
• J2850 – Injection, secretin, synthetic, human, 1 microgram
• J2860 – Injection, siltuximab, 10 mg
• J2865 – Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg
• J2916 – Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg
• J2919 – Injection, methylprednisolone sodium succinate, 5 mg
• J2941 – Injection, somatropin, 1 mg
• J2950 – Injection, promazine hcl, up to 25 mg
• J2993 – Injection, reteplase, 18.1 mg
• J2997 – Injection, alteplase recombinant, 1 mg
• J2998 – Injection, plasminogen, human-tvmh, 1 mg
• J3000 – Injection, streptomycin, up to 1 gm
• J3010 – Injection, fentanyl citrate, 0.1 mg
• J3030 – Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
• J3031 – Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
• J3032 – Injection, eptinezumab-jjmr, 1 mg
• J3055 – Injection, talquetamab-tgvs, 0.25 mg
• J3060 – Injection, taliglucerase alfa, 10 units
• J3070 – Injection, pentazocine, 30 mg
• J3090 – Injection, tedizolid phosphate, 1 mg
• J3095 – Injection, telavancin, 10 mg
• J3101 – Injection, tenecteplase, 1 mg
• J3105 – Injection, terbutaline sulfate, up to 1 mg
• J3110 – Injection, teriparatide, 10 mcg
• J3111 – Injection, romosozumab-aqqg, 1 mg
• J3121 – Injection, testosterone enanthate, 1 mg
• J3145 – Injection, testosterone undecanoate, 1 mg
• J3230 – Injection, chlorpromazine hcl, up to 50 mg
• J3240 – Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
• J3241 – Injection, teprotumumab-trbw, 10 mg
• J3243 – Injection, tigecycline, 1 mg
• J3244 – Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg
• J3245 – Injection, tildrakizumab, 1 mg
• J3246 – Injection, tirofiban hcl, 0.25 mg
• J3247 – Injection, secukinumab, intravenous, 1 mg
• J3250 – Injection, trimethobenzamide hcl, up to 200 mg
• J3260 – Injection, tobramycin sulfate, up to 80 mg
• J3262 – Injection, tocilizumab, 1 mg
• J3263 – Injection, toripalimab-tpzi, 1 mg
• J3265 – Injection, torsemide, 10 mg/ml
• J3268 – Injection, delafloxacin, 1 mg
• J3285 – Injection, treprostinil, 1 mg
• J3290 – Injection, tranexamic acid, 5 mg
• J3291 – Injection, tranexamic acid in sodium chloride, 5 mg
• J3299 – Injection, triamcinolone acetonide (xipere), 1 mg
• J3300 – Injection, triamcinolone acetonide (triesence), preservative free, 1 mg
• J3301 – Injection, triamcinolone acetonide, not otherwise specified, 10 mg
• J3302 – Injection, triamcinolone diacetate, per 5 mg
• J3303 – Injection, triamcinolone hexacetonide, per 5 mg
• J3304 – Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
• J3315 – Injection, triptorelin pamoate, 3.75 mg
• J3316 – Injection, triptorelin, extended-release, 3.75 mg
• J3350 – Injection, urea, up to 40 gm
• J3357 – Ustekinumab, for subcutaneous injection, 1 mg
• J3358 – Ustekinumab, for intravenous injection, 1 mg
• J3360 – Injection, diazepam, up to 5 mg
• J3373 – Injection, vancomycin hydrochloride, 10 mg
• J3374 – Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg
• J3375 – Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg
• J3376 – Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg
• J3379 – Injection, valproate sodium, 5 mg
• J3380 – Injection, vedolizumab, intravenous, 1 mg
• J3385 – Injection, velaglucerase alfa, 100 units
• J3386 – Injection, etuvetidigene autotemcel, per treatment
• J3387 – Injection, elivaldogene autotemcel, per treatment
• J3389 – Topical administration, prademagene zamikeracel, per treatment
• J3391 – Injection, atidarsagene autotemcel, per treatment
• J3392 – Injection, exagamglogene autotemcel, per treatment
• J3393 – Injection, betibeglogene autotemcel, per treatment
• J3394 – Injection, lovotibeglogene autotemcel, per treatment
• J3396 – Injection, verteporfin, 0.1 mg
• J3397 – Injection, vestronidase alfa-vjbk, 1 mg
• J3398 – Injection, voretigene neparvovec-rzyl, 1 billion vector genomes
• J3399 – Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes
• J3401 – Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml
• J3402 – Injection, remestemcel-l-rknd, per therapeutic dose
• J3403 – Revakinagene taroretcel-lwey, per implant
• J3404 – Injection, zopapogene imadenovec-drba suspension, per therapeutic dose
• J3405 – Injection, onasemnogene abeparvovec-brve, per treatment
• J3406 – Injection, omidubicel-onlv, per therapeutic dose
• J3410 – Injection, hydroxyzine hcl, up to 25 mg
• J3411 – Injection, thiamine hcl, 100 mg
• J3415 – Injection, pyridoxine hcl, 100 mg
• J3420 – Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
• J3424 – Injection, hydroxocobalamin, intravenous, 25 mg
• J3425 – Injection, hydroxocobalamin, intramuscular, 10 mcg
• J3430 – Injection, phytonadione (vitamin k), per 1 mg
• J3465 – Injection, voriconazole, 10 mg
• J3470 – Injection, hyaluronidase, up to 150 units
• J3471 – Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)
• J3472 – Injection, hyaluronidase, ovine, preservative free, per 1000 usp units
• J3473 – Injection, hyaluronidase, recombinant, 1 usp unit
• J3475 – Injection, magnesium sulfate, per 500 mg
• J3480 – Injection, potassium chloride, per 2 meq
• J3485 – Injection, zidovudine, 10 mg
• J3486 – Injection, ziprasidone mesylate, 10 mg
• J3489 – Injection, zoledronic acid, 1 mg
• J3490 – Unclassified drugs
• J3520 – Edetate disodium, per 150 mg
• J3530 – Nasal vaccine inhalation
• J3535 – Drug administered through a metered dose inhaler
• J3570 – Laetrile, amygdalin, vitamin b17
• J3590 – Unclassified biologics
• J3591 – Unclassified drug or biological used for esrd on dialysis
• J7030 – Infusion, normal saline solution , 1000 cc
• J7040 – Infusion, normal saline solution, sterile (500 ml = 1 unit)
• J7042 – 5% dextrose/normal saline (500 ml = 1 unit)
• J7050 – Infusion, normal saline solution, 250 cc
• J7060 – 5% dextrose/water (500 ml = 1 unit)
• J7070 – Infusion, d5w, 1000 cc
• J7100 – Infusion, dextran 40, 500 ml
• J7110 – Infusion, dextran 75, 500 ml
• J7120 – Ringers lactate infusion, up to 1000 cc
• J7121 – 5% dextrose in lactated ringers infusion, up to 1000 cc
• J7131 – Hypertonic saline solution, 1 ml
• J7165 – Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity
• J7168 – Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
• J7169 – Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg
• J7170 – Injection, emicizumab-kxwh, 0.5 mg
• J7171 – Injection, adamts13, recombinant-krhn, 10 iu
• J7172 – Injection, marstacimab-hncq, 0.5 mg
• J7173 – Injection, concizumab-mtci, 0.5 mg
• J7174 – Injection, fitusiran, 0.04 mg
• J7175 – Injection, factor x, (human), 1 i.u.
• J7176 – Injection, human fibrinogen - chmt (fesilty), 1 mg
• J7177 – Injection, human fibrinogen concentrate (fibryga), 1 mg
• J7178 – Injection, human fibrinogen concentrate, not otherwise specified, 1 mg
• J7179 – Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco
• J7180 – Injection, factor xiii (antihemophilic factor, human), 1 i.u.
• J7181 – Injection, factor xiii a-subunit, (recombinant), per iu
• J7182 – Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu
• J7183 – Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco
• J7185 – Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.
• J7186 – Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.
• J7187 – Injection, von willebrand factor complex (humate-p), per iu vwf:rco
• J7188 – Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.
• J7189 – Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram
• J7190 – Factor viii (antihemophilic factor, human) per i.u.
• J7191 – Factor viii (antihemophilic factor (porcine)), per i.u.
• J7192 – Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified
• J7193 – Factor ix (antihemophilic factor, purified, non-recombinant) per i.u.
• J7194 – Factor ix, complex, per i.u.
• J7195 – Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified
• J7196 – Injection, antithrombin recombinant, 50 i.u.
• J7197 – Antithrombin iii (human), per i.u.
• J7198 – Anti-inhibitor, per i.u.
• J7199 – Hemophilia clotting factor, not otherwise classified
• J7200 – Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu
• J7201 – Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.
• J7202 – Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.
• J7203 – Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu
• J7204 – Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu
• J7205 – Injection, factor viii fc fusion protein (recombinant), per iu
• J7207 – Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.
• J7208 – Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.
• J7209 – Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.
• J7210 – Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.
• J7211 – Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.
• J7212 – Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram
• J7213 – Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.
• J7214 – Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.
• J7294 – Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each
• J7295 – Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each
• J7296 – Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg
• J7297 – Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg
• J7298 – Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg
• J7299 – Intrauterine copper contraceptive (miudella)
• J7300 – Intrauterine copper contraceptive (paragard)
• J7301 – Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
• J7304 – Contraceptive supply, hormone containing patch, each
• J7306 – Levonorgestrel (contraceptive) implant system, including implants and supplies
• J7307 – Etonogestrel (contraceptive) implant system, including implant and supplies
• J7308 – Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
• J7311 – Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
• J7312 – Injection, dexamethasone, intravitreal implant, 0.1 mg
• J7313 – Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg
• J7314 – Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg
• J7315 – Mitomycin, ophthalmic, 0.2 mg
• J7316 – Injection, ocriplasmin, 0.125 mg
• J7318 – Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg
• J7320 – Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg
• J7321 – Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose
• J7322 – Hyaluronan or derivative, hymovis or hymovis one, for intra-articular injection, 1 mg
• J7323 – Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose
• J7324 – Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose
• J7325 – Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg
• J7326 – Hyaluronan or derivative, gel-one, for intra-articular injection, per dose
• J7327 – Hyaluronan or derivative, monovisc, for intra-articular injection, per dose
• J7328 – Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg
• J7329 – Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg
• J7330 – Autologous cultured chondrocytes, implant
• J7331 – Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg
• J7332 – Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg
• J7336 – Capsaicin 8% patch, per square centimeter
• J7340 – Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml
• J7342 – Instillation, ciprofloxacin otic suspension, 6 mg
• J7345 – Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
• J7351 – Injection, bimatoprost, intracameral implant, 1 microgram
• J7352 – Afamelanotide implant, 1 mg
• J7353 – Anacaulase-bcdb, 8.8% gel, 1 gram
• J7354 – Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
• J7355 – Injection, travoprost, intracameral implant, 1 microgram
• J7356 – Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg
• J7402 – Mometasone furoate sinus implant, (sinuva), 10 micrograms
• J7500 – Azathioprine, oral, 50 mg
• J7501 – Azathioprine, parenteral, 100 mg
• J7502 – Cyclosporine, oral, 100 mg
• J7503 – Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
• J7504 – Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg
• J7507 – Tacrolimus, immediate release, oral, 1 mg
• J7508 – Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
• J7509 – Methylprednisolone oral, per 4 mg
• J7510 – Prednisolone oral, per 5 mg
• J7511 – Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
• J7512 – Prednisone, immediate release or delayed release, oral, 1 mg
• J7515 – Cyclosporine, oral, 25 mg
• J7516 – Injection, cyclosporine, 250 mg
• J7518 – Mycophenolic acid, oral, 180 mg
• J7520 – Sirolimus, oral, 1 mg
• J7521 – Tacrolimus, granules, oral suspension, 0.1 mg
• J7524 – Mycophenolate mofetil, oral, 5 mg
• J7525 – Tacrolimus, parenteral, 5 mg
• J7526 – Injection, mycophenolate mofetil, 5 mg
• J7527 – Everolimus, oral, 0.25 mg
• J7529 – Mycophenolate mofetil, for suspension, oral, 5 mg
• J7530 – Mycophenolate mofetil (myhibbin), oral suspension, 5 mg
• J7531 – Prednisolone sodium phosphate, orally disintegrating tablet, 1 mg
• J7599 – Immunosuppressive drug, not otherwise classified
• J7601 – Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
• J7604 – Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
• J7605 – Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
• J7606 – Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
• J7607 – Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
• J7608 – Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
• J7609 – Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
• J7610 – Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
• J7611 – Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
• J7612 – Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
• J7613 – Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
• J7614 – Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
• J7615 – Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
• J7620 – Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
• J7622 – Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7624 – Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7626 – Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
• J7627 – Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
• J7628 – Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7629 – Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7631 – Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
• J7632 – Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
• J7633 – Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
• J7634 – Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
• J7635 – Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7636 – Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7637 – Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7638 – Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7639 – Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
• J7640 – Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
• J7641 – Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram
• J7642 – Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7643 – Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7644 – Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
• J7645 – Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7647 – Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7648 – Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
• J7649 – Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
• J7650 – Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7657 – Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7658 – Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
• J7659 – Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
• J7660 – Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7665 – Mannitol, administered through an inhaler, 5 mg
• J7667 – Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams
• J7668 – Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams
• J7669 – Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
• J7670 – Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
• J7674 – Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg
• J7676 – Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg
• J7677 – Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram
• J7680 – Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7681 – Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7682 – Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams
• J7683 – Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7684 – Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7685 – Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams
• J7686 – Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg
• J7699 – Noc drugs, inhalation solution administered through dme
• J7799 – Noc drugs, other than inhalation drugs, administered through dme
• J7999 – Compounded drug, not otherwise classified
• J8498 – Antiemetic drug, rectal/suppository, not otherwise specified
• J8499 – Prescription drug, oral, non chemotherapeutic, nos
• J8501 – Aprepitant, oral, 5 mg
• J8502 – Injection, aprepitant (aponvie), 1 mg
• J8510 – Busulfan; oral, 2 mg
• J8515 – Cabergoline, oral, 0.25 mg
• J8522 – Capecitabine, oral, 50 mg
• J8530 – Cyclophosphamide; oral, 25 mg
• J8540 – Dexamethasone, oral, 0.25 mg
• J8541 – Dexamethasone (hemady), oral, 0.25 mg
• J8560 – Etoposide; oral, 50 mg
• J8565 – Gefitinib, oral, 250 mg
• J8597 – Antiemetic drug, oral, not otherwise specified
• J8600 – Melphalan; oral, 2 mg
• J8610 – Methotrexate; oral, 2.5 mg
• J8611 – Methotrexate (jylamvo), oral, 2.5 mg
• J8612 – Methotrexate (xatmep), oral, 2.5 mg
• J8655 – Netupitant 300 mg and palonosetron 0.5 mg, oral
• J8670 – Rolapitant, oral, 1 mg
• J8700 – Temozolomide, oral, 5 mg
• J8705 – Topotecan, oral, 0.25 mg
• J8999 – Prescription drug, oral, chemotherapeutic, nos
• J9000 – Injection, doxorubicin hydrochloride, 10 mg
• J9003 – Leuprolide injectable (camcevi etm), 1 mg
• J9011 – Injection, datopotamab deruxtecan-dlnk, 1 mg
• J9015 – Injection, aldesleukin, per single use vial
• J9017 – Injection, arsenic trioxide, 1 mg
• J9021 – Injection, asparaginase, recombinant, (rylaze), 0.1 mg
• J9022 – Injection, atezolizumab, 10 mg
• J9023 – Injection, avelumab, 10 mg
• J9024 – Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
• J9025 – Injection, azacitidine, 1 mg
• J9026 – Injection, tarlatamab-dlle, 1 mg
• J9027 – Injection, clofarabine, 1 mg
• J9028 – Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
• J9029 – Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
• J9030 – Bcg live intravesical instillation, 1 mg
• J9032 – Injection, belinostat, 10 mg
• J9033 – Injection, bendamustine hydrochloride, not otherwise specified, 1 mg
• J9034 – Injection, bendamustine hcl (bendeka), 1 mg
• J9035 – Injection, bevacizumab, 10 mg
• J9036 – Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
• J9038 – Injection, axatilimab-csfr, 0.1 mg
• J9039 – Injection, blinatumomab, 1 microgram
• J9040 – Injection, bleomycin sulfate, 15 units
• J9041 – Injection, bortezomib, 0.1 mg
• J9042 – Injection, brentuximab vedotin, 1 mg
• J9043 – Injection, cabazitaxel, 1 mg
• J9045 – Injection, carboplatin, 50 mg
• J9046 – Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg
• J9047 – Injection, carfilzomib, 1 mg
• J9048 – Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg
• J9049 – Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg
• J9050 – Injection, carmustine, 100 mg
• J9051 – Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg
• J9052 – Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg
• J9053 – Injection, belantamab mafodotin-blmf, 0.1 mg
• J9054 – Injection, bortezomib (boruzu), 0.1 mg
• J9055 – Injection, cetuximab, 10 mg
• J9056 – Injection, bendamustine hydrochloride (vivimusta), 1 mg
• J9057 – Injection, copanlisib, 1 mg
• J9060 – Injection, cisplatin, powder or solution, 10 mg
• J9061 – Injection, amivantamab-vmjw, 2 mg
• J9062 – Injection, amivantamab 5 mg and hyaluronidase-lpuj
• J9063 – Injection, mirvetuximab soravtansine-gynx, 1 mg
• J9064 – Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg
• J9065 – Injection, cladribine, per 1 mg
• J9066 – Injection, bendamustine hydrochloride (avyxa), 1 mg
• J9071 – Injection, cyclophosphamide (auromedics), 5 mg
• J9072 – Injection, cyclophosphamide (frindovyx), 5 mg
• J9073 – Injection, cyclophosphamide (dr. reddy's), 5 mg
• J9074 – Injection, cyclophosphamide (sandoz), 5 mg
• J9075 – Injection, cyclophosphamide, not otherwise specified, 5 mg
• J9076 – Injection, cyclophosphamide (baxter), 5 mg
• J9100 – Injection, cytarabine, 100 mg
• J9118 – Injection, calaspargase pegol-mknl, 10 units
• J9119 – Injection, cemiplimab-rwlc, 1 mg
• J9120 – Injection, dactinomycin, 0.5 mg
• J9130 – Dacarbazine, 100 mg
• J9144 – Injection, daratumumab, 10 mg and hyaluronidase-fihj
• J9145 – Injection, daratumumab, 10 mg
• J9150 – Injection, daunorubicin, 10 mg
• J9153 – Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
• J9155 – Injection, degarelix, 1 mg
• J9161 – Injection, denileukin diftitox-cxdl, 1 mcg
• J9171 – Injection, docetaxel, 1 mg
• J9172 – Injection, docetaxel (docivyx), 1 mg
• J9173 – Injection, durvalumab, 10 mg
• J9174 – Injection, docetaxel (beizray), 1 mg
• J9175 – Injection, elliotts' b solution, 1 ml
• J9176 – Injection, elotuzumab, 1 mg
• J9177 – Injection, enfortumab vedotin-ejfv, 0.25 mg
• J9178 – Injection, epirubicin hcl, 2 mg
• J9179 – Injection, eribulin mesylate, 0.1 mg
• J9183 – Gemcitabine intravesical system, 225 mg
• J9184 – Injection, gemcitabine hydrochloride (avyxa), 200 mg
• J9185 – Injection, fludarabine phosphate, 50 mg
• J9186 – Injection, etoposide (avyxa), 1 mg
• J9187 – Injection, etoposide, 1 mg
• J9191 – Injection, fluorouracil (avyxa), 10 mg
• J9192 – Injection, fluorouracil, 10 mg
• J9196 – Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
• J9198 – Injection, gemcitabine hydrochloride, (infugem), 100 mg
• J9200 – Injection, floxuridine, 500 mg
• J9201 – Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
• J9202 – Goserelin acetate implant, per 3.6 mg
• J9203 – Injection, gemtuzumab ozogamicin, 0.1 mg
• J9204 – Injection, mogamulizumab-kpkc, 1 mg
• J9205 – Injection, irinotecan liposome, 1 mg
• J9206 – Injection, irinotecan, 20 mg
• J9207 – Injection, ixabepilone, 1 mg
• J9208 – Injection, ifosfamide, 1 gram
• J9209 – Injection, mesna, 200 mg
• J9210 – Injection, emapalumab-lzsg, 1 mg
• J9211 – Injection, idarubicin hydrochloride, 5 mg
• J9213 – Injection, interferon, alfa-2a, recombinant, 3 million units
• J9214 – Injection, interferon, alfa-2b, recombinant, 1 million units
• J9215 – Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu
• J9216 – Injection, interferon, gamma 1-b, 3 million units
• J9217 – Leuprolide acetate (for depot suspension), 7.5 mg
• J9218 – Leuprolide acetate, per 1 mg
• J9219 – Leuprolide acetate implant, 65 mg
• J9220 – Injection, indigotindisulfonate sodium, 1 mg
• J9223 – Injection, lurbinectedin, 0.1 mg
• J9225 – Histrelin implant (vantas), 50 mg
• J9226 – Histrelin implant (supprelin la), 50 mg
• J9227 – Injection, isatuximab-irfc, 10 mg
• J9228 – Injection, ipilimumab, 1 mg
• J9229 – Injection, inotuzumab ozogamicin, 0.1 mg
• J9230 – Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg
• J9232 – Injection, docetaxel (hospira), not therapeutically equivalent to j9171, 1 mg
• J9245 – Injection, melphalan hydrochloride, not otherwise specified, 50 mg
• J9246 – Injection, melphalan (evomela), 1 mg
• J9248 – Injection, melphalan (hepzato), 1 mg
• J9249 – Injection, melphalan (apotex), 1 mg
• J9255 – Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg
• J9256 – Injection, nipocalimab-aahu, 3 mg
• J9260 – Injection, methotrexate sodium, 50 mg
• J9261 – Injection, nelarabine, 50 mg
• J9262 – Injection, omacetaxine mepesuccinate, 0.01 mg
• J9263 – Injection, oxaliplatin, 0.5 mg
• J9264 – Injection, paclitaxel protein-bound particles, 1 mg
• J9266 – Injection, pegaspargase, per single dose vial
• J9267 – Injection, paclitaxel, 1 mg
• J9268 – Injection, pentostatin, 10 mg
• J9269 – Injection, tagraxofusp-erzs, 10 micrograms
• J9271 – Injection, pembrolizumab, 1 mg
• J9272 – Injection, dostarlimab-gxly, 10 mg
• J9273 – Injection, tisotumab vedotin-tftv, 1 mg
• J9274 – Injection, tebentafusp-tebn, 1 microgram
• J9275 – Injection, cosibelimab-ipdl, 2 mg
• J9276 – Injection, zanidatamab-hrii, 2 mg
• J9277 – Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph
• J9278 – Injection, carboplatin (avyxa), 1 mg
• J9280 – Injection, mitomycin, 5 mg
• J9281 – Mitomycin pyelocalyceal instillation, 1 mg
• J9282 – Mitomycin, intravesical instillation, 1 mg
• J9285 – Injection, olaratumab, 10 mg
• J9286 – Injection, glofitamab-gxbm, 2.5 mg
• J9289 – Injection, nivolumab, 2 mg and hyaluronidase-nvhy
• J9292 – Injection, pemetrexed dipotassium, 10 mg
• J9293 – Injection, mitoxantrone hydrochloride, per 5 mg
• J9294 – Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg
• J9295 – Injection, necitumumab, 1 mg
• J9296 – Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg
• J9297 – Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg
• J9298 – Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg
• J9299 – Injection, nivolumab, 1 mg
• J9301 – Injection, obinutuzumab, 10 mg
• J9302 – Injection, ofatumumab, 10 mg
• J9303 – Injection, panitumumab, 10 mg
• J9304 – Injection, pemetrexed (pemfexy), 10 mg
• J9305 – Injection, pemetrexed, not otherwise specified, 10 mg
• J9306 – Injection, pertuzumab, 1 mg
• J9307 – Injection, pralatrexate, 1 mg
• J9308 – Injection, ramucirumab, 5 mg
• J9309 – Injection, polatuzumab vedotin-piiq, 1 mg
• J9311 – Injection, rituximab 10 mg and hyaluronidase
• J9312 – Injection, rituximab, 10 mg
• J9313 – Injection, moxetumomab pasudotox-tdfk, 0.01 mg
• J9314 – Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg
• J9316 – Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg
• J9317 – Injection, sacituzumab govitecan-hziy, 2.5 mg
• J9318 – Injection, romidepsin, non-lyophilized, 0.1 mg
• J9319 – Injection, romidepsin, lyophilized, 0.1 mg
• J9320 – Injection, streptozocin, 1 gram
• J9321 – Injection, epcoritamab-bysp, 0.16 mg
• J9322 – Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg
• J9323 – Injection, pemetrexed ditromethamine, 10 mg
• J9324 – Injection, pemetrexed (pemrydi rtu), 10 mg
• J9325 – Injection, talimogene laherparepvec, per 1 million plaque forming units
• J9326 – Injection, telisotuzumab vedotin-tllv, 1 mg
• J9328 – Injection, temozolomide, 1 mg
• J9329 – Injection, tislelizumab-jsgr, 1mg
• J9330 – Injection, temsirolimus, 1 mg
• J9331 – Injection, sirolimus protein-bound particles, 1 mg
• J9332 – Injection, efgartigimod alfa-fcab, 2mg
• J9333 – Injection, rozanolixizumab-noli, 1 mg
• J9334 – Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc
• J9341 – Injection, thiotepa (tepylute), 1 mg
• J9342 – Injection, thiotepa, not otherwise specified, 1 mg
• J9345 – Injection, retifanlimab-dlwr, 1 mg
• J9347 – Injection, tremelimumab-actl, 1 mg
• J9348 – Injection, naxitamab-gqgk, 1 mg
• J9349 – Injection, tafasitamab-cxix, 2 mg
• J9350 – Injection, mosunetuzumab-axgb, 1 mg
• J9351 – Injection, topotecan, 0.1 mg
• J9353 – Injection, margetuximab-cmkb, 5 mg
• J9354 – Injection, ado-trastuzumab emtansine, 1 mg
• J9355 – Injection, trastuzumab, excludes biosimilar, 10 mg
• J9356 – Injection, trastuzumab, 10 mg and hyaluronidase-oysk
• J9357 – Injection, valrubicin, intravesical, 200 mg
• J9358 – Injection, fam-trastuzumab deruxtecan-nxki, 1 mg
• J9359 – Injection, loncastuximab tesirine-lpyl, 0.075 mg
• J9360 – Injection, vinblastine sulfate, 1 mg
• J9361 – Injection, efbemalenograstim alfa-vuxw, 0.5 mg
• J9362 – Injection, trabectedin, 0.01 mg
• J9370 – Vincristine sulfate, 1 mg
• J9376 – Injection, pozelimab-bbfg, 1 mg
• J9380 – Injection, teclistamab-cqyv, 0.5 mg
• J9381 – Injection, teplizumab-mzwv, 5 mcg
• J9382 – Injection, zenocutuzumab-zbco, 1 mg
• J9390 – Injection, vinorelbine tartrate, 10 mg
• J9393 – Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg
• J9394 – Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg
• J9395 – Injection, fulvestrant, 25 mg
• J9400 – Injection, ziv-aflibercept, 1 mg
• J9600 – Injection, porfimer sodium, 75 mg
• J9601 – Injection, linvoseltamab-gcpt, 1 mg
• J9999 – Not otherwise classified, antineoplastic drugs

Discontinued J codes

• J0135 – Injection, adalimumab, 20 mgDiscontinued December 31, 2024
• J0150 – Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)Discontinued December 31, 2014
• J0151 – Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)Discontinued December 31, 2014
• J0171 – Injection, adrenalin, epinephrine, 0.1 mgDiscontinued June 30, 2025
• J0172 – Injection, aducanumab-avwa, 2 mgDiscontinued December 31, 2025
• J0173 – Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mgDiscontinued June 30, 2025
• J0190 – Injection, biperiden lactate, per 5 mgDiscontinued December 31, 2025
• J0200 – Injection, alatrofloxacin mesylate, 100 mgDiscontinued December 31, 2025
• J0205 – Injection, alglucerase, per 10 unitsDiscontinued December 31, 2025
• J0215 – Injection, alefacept, 0.5 mgDiscontinued December 31, 2025
• J0288 – Injection, amphotericin b cholesteryl sulfate complex, 10 mgDiscontinued December 31, 2025
• J0350 – Injection, anistreplase, per 30 unitsDiscontinued December 31, 2025
• J0365 – Injection, aprotonin, 10,000 kiuDiscontinued December 31, 2025
• J0380 – Injection, metaraminol bitartrate, per 10 mgDiscontinued December 31, 2025
• J0395 – Injection, arbutamine hcl, 1 mgDiscontinued December 31, 2025
• J0576 – Injection, buprenorphine extended-release (brixadi), 1 mgDiscontinued March 31, 2024
• J0610 – Injection, calcium gluconate (fresenius kabi), per 10 mlDiscontinued March 31, 2023
• J0611 – Injection, calcium gluconate (wg critical care), per 10 mlDiscontinued March 31, 2023
• J0640 – Injection, leucovorin calcium, per 50 mgDiscontinued September 30, 2026
• J0693 – Injection, cefiderocol, 5 mgDiscontinued September 30, 2021
• J0710 – Injection, cephapirin sodium, up to 1 gmDiscontinued December 31, 2025
• J0715 – Injection, ceftizoxime sodium, per 500 mgDiscontinued December 31, 2025
• J0760 – Injection, colchicine, per 1 mgDiscontinued December 31, 2016
• J0795 – Injection, corticorelin ovine triflutate, 1 microgramDiscontinued December 31, 2025
• J0800 – Injection, corticotropin, up to 40 unitsDiscontinued September 30, 2023
• J0833 – Injection, cosyntropin, not otherwise specified, 0.25 mgDiscontinued December 31, 2018
• J0886 – Injection, epoetin alfa, 1000 units (for esrd on dialysis)Discontinued December 31, 2015
• J0889 – Daprodustat, oral, 1 mg, (for esrd on dialysis)Discontinued December 31, 2025
• J0900 – Injection, testosterone enanthate and estradiol valerate, up to 1 ccDiscontinued December 31, 2014
• J1020 – Injection, methylprednisolone acetate, 20 mgDiscontinued March 31, 2024
• J1030 – Injection, methylprednisolone acetate, 40 mgDiscontinued March 31, 2024
• J1040 – Injection, methylprednisolone acetate, 80 mgDiscontinued March 31, 2024
• J1060 – Injection, testosterone cypionate and estradiol cypionate, up to 1 mlDiscontinued December 31, 2014
• J1070 – Injection, testosterone cypionate, up to 100 mgDiscontinued December 31, 2014
• J1080 – Injection, testosterone cypionate, 1 cc, 200 mgDiscontinued December 31, 2014
• J1094 – Injection, dexamethasone acetate, 1 mgDiscontinued March 31, 2025
• J1170 – Injection, hydromorphone, up to 4 mgDiscontinued September 30, 2024
• J1267 – Injection, doripenem, 10 mgDiscontinued December 31, 2025
• J1300 – Injection, eculizumab, 10 mgDiscontinued March 31, 2025
• J1330 – Injection, ergonovine maleate, up to 0.2 mgDiscontinued December 31, 2025
• J1443 – Injection, ferric pyrophosphate citrate solution (triferic), 0.1 mg of ironDiscontinued December 31, 2025
• J1444 – Injection, ferric pyrophosphate citrate powder, 0.1 mg of ironDiscontinued December 31, 2025
• J1445 – Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of ironDiscontinued December 31, 2025
• J1446 – Injection, tbo-filgrastim, 5 microgramsDiscontinued December 31, 2015
• J1452 – Injection, fomivirsen sodium, intraocular, 1.65 mgDiscontinued December 31, 2025
• J1457 – Injection, gallium nitrate, 1 mgDiscontinued December 31, 2025
• J1562 – Injection, immune globulin (vivaglobin), 100 mgDiscontinued December 31, 2025
• J1590 – Injection, gatifloxacin, 10 mgDiscontinued December 31, 2016
• J1620 – Injection, gonadorelin hydrochloride, per 100 mcgDiscontinued December 31, 2025
• J1655 – Injection, tinzaparin sodium, 1000 iuDiscontinued December 31, 2025
• J1710 – Injection, hydrocortisone sodium phosphate, up to 50 mgDiscontinued December 31, 2025
• J1725 – Injection, hydroxyprogesterone caproate, 1 mgDiscontinued December 31, 2017
• J1810 – Injection, droperidol and fentanyl citrate, up to 2 ml ampuleDiscontinued March 31, 2025
• J1840 – Injection, kanamycin sulfate, up to 500 mgDiscontinued March 31, 2024
• J1850 – Injection, kanamycin sulfate, up to 75 mgDiscontinued March 31, 2024
• J1890 – Injection, cephalothin sodium, up to 1 gramDiscontinued March 31, 2025
• J1940 – Injection, furosemide, up to 20 mgDiscontinued March 31, 2025
• J1941 – Injection, furosemide (furoscix), 20 mgDiscontinued September 30, 2026
• J1942 – Injection, aripiprazole lauroxil, 1 mgDiscontinued September 30, 2019
• J1945 – Injection, lepirudin, 50 mgDiscontinued December 31, 2025
• J1953 – Injection, levetiracetam, 10 mgDiscontinued September 30, 2026
• J2001 – Injection, lidocaine hcl for intravenous infusion, 10 mgDiscontinued September 30, 2024
• J2150 – Injection, mannitol, 25% in 50 mlDiscontinued September 30, 2025
• J2271 – Injection, morphine sulfate, 100mgDiscontinued December 31, 2014
• J2275 – Injection, morphine sulfate (preservative-free sterile solution), per 10 mgDiscontinued December 31, 2014
• J2310 – Injection, naloxone hydrochloride, per 1 mgDiscontinued June 30, 2025
• J2311 – Injection, naloxone hydrochloride (zimhi), 1 mgDiscontinued June 30, 2025
• J2370 – Injection, phenylephrine hcl, up to 1 mlDiscontinued June 30, 2023
• J2400 – Injection, chloroprocaine hydrochloride, per 30 mlDiscontinued December 31, 2022
• J2503 – Injection, pegaptanib sodium, 0.3 mgDiscontinued September 30, 2025
• J2504 – Injection, pegademase bovine, 25 iuDiscontinued December 31, 2025
• J2505 – Injection, pegfilgrastim, 6 mgDiscontinued December 31, 2021
• J2513 – Injection, pentastarch, 10% solution, 100 mlDiscontinued December 31, 2025
• J2780 – Injection, ranitidine hydrochloride, 25 mgDiscontinued June 30, 2024
• J2796 – Injection, romiplostim, 10 microgramsDiscontinued December 31, 2024
• J2806 – Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 microgramsDiscontinued December 31, 2024
• J2910 – Injection, aurothioglucose, up to 50 mgDiscontinued December 31, 2025
• J2920 – Injection, methylprednisolone sodium succinate, up to 40 mgDiscontinued March 31, 2024
• J2930 – Injection, methylprednisolone sodium succinate, up to 125 mgDiscontinued March 31, 2024
• J2940 – Injection, somatrem, 1 mgDiscontinued December 31, 2025
• J2995 – Injection, streptokinase, per 250,000 iuDiscontinued December 31, 2025
• J3120 – Injection, testosterone enanthate, up to 100 mgDiscontinued December 31, 2014
• J3130 – Injection, testosterone enanthate, up to 200 mgDiscontinued December 31, 2014
• J3140 – Injection, testosterone suspension, up to 50 mgDiscontinued December 31, 2014
• J3150 – Injection, testosterone propionate, up to 100 mgDiscontinued December 31, 2014
• J3280 – Injection, thiethylperazine maleate, up to 10 mgDiscontinued December 31, 2025
• J3305 – Injection, trimetrexate glucuronate, per 25 mgDiscontinued December 31, 2025
• J3310 – Injection, perphenazine, up to 5 mgDiscontinued December 31, 2025
• J3320 – Injection, spectinomycin dihydrochloride, up to 2 gmDiscontinued December 31, 2025
• J3355 – Injection, urofollitropin, 75 iuDiscontinued December 31, 2025
• J3364 – Injection, urokinase, 5000 iu vialDiscontinued December 31, 2025
• J3365 – Injection, iv, urokinase, 250,000 i.u. vialDiscontinued December 31, 2025
• J3370 – Injection, vancomycin hcl, 500 mgDiscontinued June 30, 2025
• J3371 – Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mgDiscontinued June 30, 2025
• J3372 – Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mgDiscontinued June 30, 2025
• J3400 – Injection, triflupromazine hcl, up to 20 mgDiscontinued December 31, 2025
• J7302 – Levonorgestrel-releasing intrauterine contraceptive system, 52 mgDiscontinued December 31, 2015
• J7303 – Contraceptive supply, hormone containing vaginal ring, eachDiscontinued September 30, 2021
• J7309 – Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gramDiscontinued December 31, 2025
• J7310 – Ganciclovir, 4.5 mg, long-acting implantDiscontinued December 31, 2025
• J7333 – Hyaluronan or derivative, visco-3, for intra-articular injection, per doseDiscontinued March 31, 2021
• J7335 – Capsaicin 8% patch, per 10 square centimetersDiscontinued December 31, 2014
• J7401 – Mometasone furoate sinus implant, 10 microgramsDiscontinued March 31, 2021
• J7505 – Muromonab-cd3, parenteral, 5 mgDiscontinued December 31, 2025
• J7506 – Prednisone, oral, per 5 mgDiscontinued December 31, 2015
• J7513 – Daclizumab, parenteral, 25 mgDiscontinued December 31, 2025
• J7514 – Mycophenolate mofetil (myhibbin), oral suspension, 100 mgDiscontinued September 30, 2026
• J7517 – Mycophenolate mofetil, oral, 250 mgDiscontinued September 30, 2026
• J7519 – Injection, mycophenolate mofetil, 10 mgDiscontinued September 30, 2026
• J7528 – Mycophenolate mofetil, for suspension, oral, 100 mgDiscontinued September 30, 2026
• J8520 – Capecitabine, oral, 150 mgDiscontinued September 30, 2024
• J8521 – Capecitabine, oral, 500 mgDiscontinued September 30, 2024
• J8562 – Fludarabine phosphate, oral, 10 mgDiscontinued December 31, 2025
• J8650 – Nabilone, oral, 1 mgDiscontinued December 31, 2025
• J9010 – Injection, alemtuzumab, 10 mgDiscontinued December 31, 2015
• J9019 – Injection, asparaginase (erwinaze), 1,000 iuDiscontinued December 31, 2025
• J9020 – Injection, asparaginase, not otherwise specified, 10,000 unitsDiscontinued December 31, 2025
• J9031 – Bcg (intravesical) per instillationDiscontinued June 30, 2019
• J9037 – Injection, belantamab mafodotin-blmf, 0.5 mgDiscontinued March 31, 2025
• J9044 – Injection, bortezomib, not otherwise specified, 0.1 mgDiscontinued December 31, 2022
• J9058 – Injection, bendamustine hydrochloride (apotex), 1 mgDiscontinued December 31, 2024
• J9059 – Injection, bendamustine hydrochloride (baxter), 1 mgDiscontinued December 31, 2024
• J9070 – Cyclophosphamide, 100 mgDiscontinued March 31, 2024
• J9098 – Injection, cytarabine liposome, 10 mgDiscontinued December 31, 2025
• J9151 – Injection, daunorubicin citrate, liposomal formulation, 10 mgDiscontinued December 31, 2025
• J9160 – Injection, denileukin diftitox, 300 microgramsDiscontinued December 31, 2023
• J9165 – Injection, diethylstilbestrol diphosphate, 250 mgDiscontinued December 31, 2025
• J9181 – Injection, etoposide, 10 mgDiscontinued September 30, 2026
• J9190 – Injection, fluorouracil, 500 mgDiscontinued September 30, 2026
• J9199 – Injection, gemcitabine hydrochloride (infugem), 200 mgDiscontinued June 30, 2020
• J9212 – Injection, interferon alfacon-1, recombinant, 1 microgramDiscontinued December 31, 2025
• J9247 – Injection, melphalan flufenamide, 1mgDiscontinued March 31, 2025
• J9250 – Methotrexate sodium, 5 mgDiscontinued March 31, 2024
• J9258 – Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mgDiscontinued September 30, 2024
• J9259 – Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mgDiscontinued December 31, 2024
• J9265 – Injection, paclitaxel, 30 mgDiscontinued December 31, 2014
• J9270 – Injection, plicamycin, 2.5 mgDiscontinued December 31, 2025
• J9300 – Injection, gemtuzumab ozogamicin, 5 mgDiscontinued December 31, 2017
• J9310 – Injection, rituximab, 100 mgDiscontinued December 31, 2018
• J9315 – Injection, romidepsin, 1 mgDiscontinued September 30, 2021
• J9340 – Injection, thiotepa, 15 mgDiscontinued June 30, 2025
• J9352 – Injection, trabectedin, 0.1 mgDiscontinued September 30, 2026
• J9371 – Injection, vincristine sulfate liposome, 1 mgDiscontinued June 30, 2024